if we settle with generics, saving our patents, and protecting our US pricing there will be no risk.
I hope I am wrong in this regard but EU Big 5 are tough on bargaining their prices.
Maybe the EU will make an exception because the US generic indication is different but I would love to see examples where EU pricing is 2X to 3X higher than the US.